Bendamustine and Rituximab As Salvage Therapy In Patients With Chronic Lymphoproliferative Disorders
Clinical trial NCT01224769 · COMPLETED
Trial details
- NCT number
- NCT01224769
- Sponsor
- Gruppo Italiano Studio Linfomi
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2005-09-01
- Primary completion
- 2009-12-01
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.